Literature DB >> 17939931

The transcription strategy of bovine adeno-associated virus (B-AAV) combines features of both adeno-associated virus type 2 (AAV2) and type 5 (AAV5).

Chaoyang Ye1, David J Pintel.   

Abstract

The parvoviruses bovine adeno-associated virus (B-AAV) and adeno-associated virus type 5 (AAV5) have similar transcription maps. However, while the AAV5 capsid gene promoter P41 possesses a high basal level in 293 cells, and is further activated only poorly by Rep during adenovirus type 5 (Ad5) infection, the B-AAV P41 promoter has a low basal activity within RepCap constructs in these cells and can be strongly activated by its Rep protein in the presence of Ad5 when a Rep-binding element (RBE) is included in cis at either end of the molecule. These differences are not due to differences in the intrinsic activating capability of the individual Rep proteins. Both viral promoters contain AP1 and CRE elements that contribute to their basal activity; however, the nature of the B-AAV P41 promoter itself and the surrounding sequences contribute to its relatively lower basal activity. In addition, the B-AAV upstream transcription units themselves also are activated in the presence of Ad5 and Rep. Thus, although the transcription map of B-AAV is much more closely related to AAV5, activation of its promoters is functionally more like the prototype AAV2.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17939931      PMCID: PMC2180392          DOI: 10.1016/j.virol.2007.09.007

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  19 in total

1.  The adeno-associated virus type 2 Rep protein regulates RNA processing via interaction with the transcription template.

Authors:  Jianming Qiu; David J Pintel
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

2.  Characterization of the transcription profile of adeno-associated virus type 5 reveals a number of unique features compared to previously characterized adeno-associated viruses.

Authors:  Jianming Qiu; Ramnath Nayak; Gregory E Tullis; David J Pintel
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

3.  Isolation of an adeno associated virus from sheep. Brief report.

Authors:  J K Clarke; J B McFerran; E R McKillop; W L Curran
Journal:  Arch Virol       Date:  1979       Impact factor: 2.574

4.  Sequences required for coordinate induction of adeno-associated virus p19 and p40 promoters by Rep protein.

Authors:  D M McCarty; M Christensen; N Muzyczka
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

5.  Accumulation of MVM gene products is differentially regulated by transcription initiation, RNA processing and protein stability.

Authors:  R V Schoborg; D J Pintel
Journal:  Virology       Date:  1991-03       Impact factor: 3.616

6.  Nonsense mutations inhibit splicing of MVM RNA in cis when they interrupt the reading frame of either exon of the final spliced product.

Authors:  L K Naeger; R V Schoborg; Q Zhao; G E Tullis; D J Pintel
Journal:  Genes Dev       Date:  1992-06       Impact factor: 11.361

7.  Isolation and characterization of adeno-associated viruses from bovine adenovirus types 1 and 2.

Authors:  A C Myrup; S B Mohanty; F M Hetrick
Journal:  Am J Vet Res       Date:  1976-08       Impact factor: 1.156

8.  The adeno-associated virus type 2 p40 promoter requires a proximal Sp1 interaction and a p19 CArG-like element to facilitate Rep transactivation.

Authors:  D J Pereira; N Muzyczka
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

9.  Recombination within the nonstructural genes of the parvovirus minute virus of mice (MVM) generates functional levels of wild-type NS1, which can be detected in the absence of selective pressure following transfection of nonreplicating plasmids.

Authors:  J L Pearson; D J Pintel
Journal:  Virology       Date:  2000-03-30       Impact factor: 3.616

10.  Haemagglutinating adeno-associated virus (AAV) in association with bovine adenovirus type 1. Brief report.

Authors:  E Luchsinger; R Strobbe; G Wellemans; D Dekegel; S Sprecher-Goldberger
Journal:  Arch Gesamte Virusforsch       Date:  1970
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.